Ladenburg Thalmann Financial Services’s Acorda Therapeutics ACOR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$4K	Hold	17	–	–	﹤0.01%	4905
2019 Q3	$6K	Hold	17	–	–	﹤0.01%	4639
2019 Q2	$15K	Sell	17 -1	-6%	-$1.23K	﹤0.01%	4247
2019 Q1	$30K	Hold	18	–	–	﹤0.01%	3760
2018 Q4	$34K	Hold	18	–	–	﹤0.01%	3529
2018 Q3	$43K	Hold	18	–	–	﹤0.01%	3416
2018 Q2	$52K	Hold	18	–	–	﹤0.01%	3230
2018 Q1	$52K	Hold	18	–	–	﹤0.01%	3230
2017 Q4	$47K	Hold	18	–	–	﹤0.01%	3265
2017 Q3	$52K	Buy	18 +13	+260%	+$34.2K	﹤0.01%	3061
2017 Q2	$12K	Hold	5	–	–	﹤0.01%	3923
2017 Q1	$13K	Buy	+5	New	+$14.4K	﹤0.01%	3850
2016 Q4	–	Hold	0	–	–	–	4980
2016 Q3	–	Hold	0	–	–	–	4682
2016 Q2	–	Hold	0	–	–	–	4644
2016 Q1	–	Sell	-2	Closed	-$8.3K	–	4587
2015 Q4	$7K	Hold	2	–	–	﹤0.01%	3907
2015 Q3	$5K	Sell	2 -8	-80%	-$31K	﹤0.01%	3964
2015 Q2	$41K	Hold	10	–	–	﹤0.01%	2732
2015 Q1	$41K	Buy	10 +3	+43%	+$13.7K	﹤0.01%	2709
2014 Q4	$33K	Hold	7	–	–	﹤0.01%	2645
2014 Q3	$27K	Buy	7 +6	+600%	+$22.5K	﹤0.01%	2448
2014 Q2	$3K	Hold	1	–	–	﹤0.01%	3563
2014 Q1	$4K	Hold	1	–	–	﹤0.01%	3362
2013 Q4	$3K	Hold	1	–	–	﹤0.01%	3441
2013 Q3	$3K	Hold	1	–	–	﹤0.01%	3372
2013 Q2	$3K	Buy	+1	New	+$4.12K	﹤0.01%	3252

Other funds holding ACOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ACOR Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Acorda Therapeutics (ACOR) position steady in Q4 2019 at 17 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4905.

Ladenburg Thalmann Financial Services first reported a position in ACOR in Q2 2013 and has held it in 23 quarters since. The position peaked at $52K in Q2 2018. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

Ladenburg Thalmann Financial Services held 17 shares of Acorda Therapeutics worth $4K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Acorda Therapeutics share count unchanged in Q4 2019.
Acorda Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4905 holding.
Ladenburg Thalmann Financial Services first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 23 quarters since.
Ladenburg Thalmann Financial Services's Acorda Therapeutics position peaked at $52K in Q2 2018.
121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.